CDC Viral Hepatitis Professional Tools
CDC’s compilation of resources for diagnosing and managing hepatitis A, B, and C.
Service: Clinical
STD Expert Hour Webinar – Delivering Sexual Health Services in the Time of COVID-19
August 13, 2020
The coronavirus (COVID-19) is impacting the delivery of sexual health services in California and throughout the United States. Dr. Ina Park and Dr. Rosalyn Plotzker provide an overview of recent CDC recommendations for STD diagnosis and treatment when in-person exams and visits are limited. They also discuss best practices for the use of telehealth and home-testing for STD care and PrEP management.
Drs. Park and Plotzker cover the following learning objectives for this webinar:
- Share implementation strategies for self-collected testing to minimize clinician exposure to COVID-19 when seeing clients for STD-related symptoms
- Identify changes to recommended syndromic treatment of urethritis, including treatment for gonorrhea and chlamydia
- Describe management recommendations for patients with genital ulcer disease
- Discuss HIV PrEP telehealth management approaches to ensure continuation of PrEP use for clients who are unable to get care in a clinic setting during and after the COVID-19 public health emergency
STD Expert Hour Webinar – Genital Dermatology 101
June 1, 2020
Dr. Kenneth Katz covers the following learning objectives for this webinar:
- Differentiate between genital skin diseases
- Formulate differential diagnoses for genital skin disease
- Identify genital skin diseases that warrant referral to specialty care
National Coalition for Sexual Health Tools for Healthcare Providers
This guide can help healthcare providers better integrate sexual health conversations and recommended preventive services into routine visits with adolescents and adults.
STD Expert Hour Webinar – PrEP: What’s the 2- 1-1?
August 13, 2019
Dr. Oliver Bacon facilitates an audience-led panel discussion with PrEP Experts and covers the following learning objectives for this webinar:
- Be familiar with the evidence supporting 2-1-1 PrEP (also known as on-demand PrEP, sex-based PrEP, and pericoital PrEP)
- Be able to counsel patients on the details of 2-1-1 dosing, including how to switch between 2-1-1 and daily PrEP
- Be familiar with the current thinking about how to offer 2-1-1 dosing (who would & would not benefit from 2-1-1 dosing, how to prescribe, & follow-up care)
STD Expert Hour Webinar – Vaginitis Cases
May 15, 2019
Dr. Caroline Mitchell covers the following learning objectives for this webinar:
- Describe the normal vaginal milieu and changes that are associated with vaginal pathology, to better diagnose and treat vaginal infections
- Discuss the most common causes of vaginitis, to reduce infectiousness and decrease transmission
- Summarize the current treatment guidelines for vaginitis, to ensure appropriate treatment and follow-up testing
Extragenital Screening
Don’t forget to swab! Among men who have sex with men, 84% of gonorrhea and chlamydia infections would be missed with urine-only screening1. Make sure your clients are screened for gonorrhea and chlamydia of the throat and rectum.
| What: | Extragenital Screening for Gonorrhea and Chlamydia |
| Where: | Rectum and throat |
| Who: | Men who have sex with men (MSM), transgender women, people living with HIV, and people on PrEP who report having receptive anal and/or oral sex |
| When: | At least annually, or every 3 to 6 months as needed based on exposure |
| Why: | When urine-only screening is performed, up to 90% of rectal gonorrhea and 77% of rectal chlamydia infections remain untreated1. HIV-negative men diagnosed with rectal infections are excellent candidates for PrEP, because they have a high risk of HIV infection |
| How: | Swab specimen (self or clinician-collected swab) |
The California Prevention Training Center supports clinics and providers in implementing rectal and pharyngeal STI screening.
For more information, contact us.
Resources for Providers
Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending MSM, CDC MMWR
April 11, 2019
CA Department of Public Health, Dear Colleague Letter
February 20, 2019
National Coalition of STD Directors – Extragenital Testing
NYC Department of Health and Mental Hygiene – STI’s Among MSM Protocol Card
Resources for Clinics
Self Swab Instructional Posters:
CDC Recommendations for Laboratory-Based Detection of Gonorrhea and Chlamydia, March 14, 2014
Verification of Patient Self-Collected Extragenital Nucleic Acid Amplification Tests
- Marcus JL, Bernstein KT, Kohn RP, Liska S, Philip SS. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sexually transmitted diseases. 2011 Oct 1;38(10):922-4.
STD Expert Hour Webinar – Sexual History Taking
February 6, 2019
Yvonne Piper RN, FNP covers the following learning objectives for this webinar:
- Describe 5 key components of a routine sexual history to reduce infectiousness and decrease STD/HIV transmission
- Demonstrate respectful, non-judgmental communication skills to discuss sexual practices, sexual risks, and risk reduction strategies with patients
- Understand effective methods of dialogue with patients regarding issues of sexual history and sexual behaviors, to improve communication with patients and patient outcomes
- Discuss the advantages and disadvantages of open-ended and closed questions to enhance sexual history taking
Congenital Syphilis Algorithm
This algorithm provides recommendations for the evaluation and management of infants <30 days old with in-utero exposure to syphilis
Extragenital Screening Resources
Extragenital (rectum and throat) gonorrhea and chlamydia screening resources for providers, clinics, and patients.
